Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and
safety of odevixibat compared to placebo in children with biliary atresia who have undergone
a Kasai hepatoportoenterostomy.
Biliary Atresia Study in Infants and Children
Age: Birth - 111 days
Little is known about the factors that cause biliary atresia nor the factors that influence
disease progression. The purpose of this study is to collect the pertinent clinical
information, genetic material and body fluid samples to enable investigators to address th...
A Prospective Database of Infants With Cholestasis
Age: 6 months - 20 years
Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions
are the most common causes of jaundice and hyperbilirubinemia that continue beyond the
newborn period. The long term goal of the Childhood Liver Disease Research Network (Chi...
Age: Birth - 6 months